Gremese, Elisa
 Distribuzione geografica
Continente #
NA - Nord America 8.717
EU - Europa 6.860
AS - Asia 6.390
SA - Sud America 1.501
AF - Africa 274
OC - Oceania 35
Continente sconosciuto - Info sul continente non disponibili 21
AN - Antartide 2
Totale 23.800
Nazione #
US - Stati Uniti d'America 8.406
SG - Singapore 3.026
CN - Cina 1.616
IT - Italia 1.336
BR - Brasile 1.255
DE - Germania 1.194
SE - Svezia 1.132
FR - Francia 651
PL - Polonia 552
IE - Irlanda 410
UA - Ucraina 384
GB - Regno Unito 354
VN - Vietnam 337
IN - India 291
ID - Indonesia 262
FI - Finlandia 228
RU - Federazione Russa 187
CA - Canada 173
HK - Hong Kong 138
TR - Turchia 106
AR - Argentina 95
BD - Bangladesh 93
MX - Messico 89
JP - Giappone 84
BE - Belgio 75
ZA - Sudafrica 75
IQ - Iraq 72
NL - Olanda 68
AT - Austria 55
KR - Corea 53
CI - Costa d'Avorio 52
SA - Arabia Saudita 49
ES - Italia 44
IR - Iran 43
VE - Venezuela 39
PK - Pakistan 38
MA - Marocco 35
EC - Ecuador 34
CZ - Repubblica Ceca 33
AU - Australia 31
CH - Svizzera 28
LT - Lituania 24
TN - Tunisia 21
CO - Colombia 20
EG - Egitto 20
AE - Emirati Arabi Uniti 18
CL - Cile 18
JO - Giordania 18
IL - Israele 17
PH - Filippine 17
UZ - Uzbekistan 17
KE - Kenya 16
PE - Perù 13
DZ - Algeria 12
EU - Europa 12
MY - Malesia 12
PY - Paraguay 12
RO - Romania 12
AZ - Azerbaigian 11
GR - Grecia 11
NP - Nepal 11
TW - Taiwan 9
UY - Uruguay 9
CR - Costa Rica 8
EE - Estonia 8
HN - Honduras 8
JM - Giamaica 8
NG - Nigeria 8
A2 - ???statistics.table.value.countryCode.A2??? 7
DK - Danimarca 7
LV - Lettonia 7
PT - Portogallo 7
RS - Serbia 7
BG - Bulgaria 6
BO - Bolivia 6
LA - Repubblica Popolare Democratica del Laos 6
MD - Moldavia 6
TT - Trinidad e Tobago 6
AL - Albania 5
AO - Angola 5
GE - Georgia 5
HU - Ungheria 5
KG - Kirghizistan 5
LK - Sri Lanka 5
NO - Norvegia 5
PA - Panama 5
TH - Thailandia 5
ET - Etiopia 4
LU - Lussemburgo 4
SK - Slovacchia (Repubblica Slovacca) 4
SN - Senegal 4
AM - Armenia 3
DO - Repubblica Dominicana 3
GA - Gabon 3
KH - Cambogia 3
KW - Kuwait 3
KZ - Kazakistan 3
LB - Libano 3
MK - Macedonia 3
NZ - Nuova Zelanda 3
Totale 23.746
Città #
Singapore 1.351
Chandler 1.270
Ashburn 921
Warsaw 498
Dublin 385
Beijing 346
New York 289
Fairfield 244
Rome 243
Jakarta 242
Ann Arbor 234
Wilmington 234
Dearborn 225
Los Angeles 221
Jacksonville 214
San Mateo 204
Woodbridge 193
Milan 187
Houston 181
Dallas 176
Nanjing 164
Munich 161
Boston 156
Seattle 156
Hefei 154
Hong Kong 131
Chicago 129
Cattolica 126
São Paulo 117
The Dalles 116
Princeton 112
Ho Chi Minh City 105
Frankfurt am Main 104
Moscow 98
Bremen 96
Hanoi 87
Cambridge 84
Marseille 80
Lawrence 77
Helsinki 75
London 68
Brussels 66
Redwood City 63
Tokyo 60
Pune 54
Abidjan 52
Buffalo 52
Nuremberg 52
Boardman 50
North Bergen 49
Seoul 49
Izmir 48
Nanchang 46
Montreal 44
Norwalk 41
Santa Clara 41
Turku 40
Rio de Janeiro 39
Hangzhou 37
Toronto 36
Kent 34
Johannesburg 33
Kunming 33
Redmond 33
Tianjin 33
Denver 32
Hebei 31
Atlanta 30
Chennai 30
Lappeenranta 30
Phoenix 30
Brooklyn 29
Lancaster 29
Orem 29
Shanghai 29
Guangzhou 28
Falls Church 27
Mexico City 27
Shenyang 27
Stockholm 27
Washington 27
Baghdad 26
Mountain View 26
San Francisco 24
Vienna 24
Amsterdam 23
Brasília 23
Brno 23
Dhaka 23
Düsseldorf 23
Jiaxing 23
Naples 23
Nürnberg 23
Augusta 22
Curitiba 21
Manchester 21
Poplar 21
Portsmouth 21
Andover 20
Hyderabad 20
Totale 12.231
Nome #
Post-COVID-19 global health strategies: the need for an interdisciplinary approach 498
Porphyromonas gingivalis and the pathogenesis of rheumatoid arthritis: analysis of various compartments including the synovial tissue 421
The prognostic significance of the Birmingham Vasculitis Activity Score (BVAS) with systemic vasculitis patients transferred to the intensive care unit (ICU) 346
MicroRNA-34a dependent regulation of AXL controls the activation of dendritic cells in inflammatory arthritis 328
Differential synovial tissue biomarkers among psoriatic arthritis and rheumatoid factor/anti-citrulline antibody-negative rheumatoid arthritis 323
Overweight/obesity affects histological features and inflammatory gene signature of synovial membrane of Rheumatoid Arthritis 294
B cell subsets in the joint compartments of seropositive and seronegative RA and non-RA arthritides express memory markers and ZAP-70 and characterize the aggregate pattern irrespectively of the autoantibody status. 245
MicroRNA-155-at the Critical Interface of Innate and Adaptive Immunity in Arthritis. 243
COVID-19 atypical Parsonage-Turner syndrome: a case report 219
Synovial fluid-derived T helper 17 cells correlate with inflammatory activity in arthritis, irrespectively of diagnosis. 208
Post-COVID-19 global health strategies: the need for an interdisciplinary approach 208
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 197
Fatigue in Covid-19 survivors: The potential impact of a nutritional supplement on muscle strength and function 196
Distinct synovial tissue macrophage subsets regulate inflammation and remission in rheumatoid arthritis 193
B-cell subsets in the joint compartments of seropositive and seronegative rheumatoid arthritis (RA) and No-RA arthritides express memory markers and ZAP70 and characterize the aggregate pattern irrespectively of the autoantibody status 181
Porphyromonas gingivalis and the pathogenesis of rheumatoid arthritis: analysis of various compartments including the synovial tissue. 180
Fatigue in Covid-19 survivors: The potential impact of a nutritional supplement on muscle strength and function 175
MicroRNA-155 influences B-cell function through PU.1 in rheumatoid arthritis 172
Chemerin and PEDF are metaflammation-related biomarkers of disease activity and obesity in rheumatoid arthritis 169
Very early rheumatoid arthritis is the major predictor of major outcome: clinical ACR remission and radiographic non-progression. 158
The role of High-mobility group box protein 1 in collagen antibody-induced arthritis is dependent on Vascular endothelial growth factor. 158
Proton pump inhibitors in rheumatic diseases: clinical practice, drug interactions, bone fractures and risk of infections 157
Adult onset Still's disease and pregnancy 157
An autosomal recessive DNASE1L3-related autoimmune disease with unusual clinical presentation mimicking systemic lupus erythematosus 157
Achievement of sustained deep remission with adalimumab in a patient with both refractory ulcerative colitis and seronegative erosive rheumatoid arthritis 156
ZAP-70+ B Cell Subset Influences Response to B Cell Depletion Therapy and Early Repopulation in Rheumatoid Arthritis 154
Haemophilus parasuis (Glaesserella parasuis) as a Potential Driver of Molecular Mimicry and Inflammation in Rheumatoid Arthritis 154
Allele *2 of the HS1,2A enhancer of the Ig regulatory region associates with rheumatoid arthritis 153
Gemelli decision tree Algorithm to Predict the need for home monitoring or hospitalization of confirmed and unconfirmed COVID-19 patients (GAP-Covid19): preliminary results from a retrospective cohort study 151
Detection of bone erosions in early rheumatoid arthritis: 3D ultrasonography versus computed tomography 148
Residual respiratory impairment after COVID-19 pneumonia 146
Memory B cell subsets and plasmablasts are lower in early than in long-standing rheumatoid arthritis 146
Body weight, gender and response to TNF-α blockers in axial spondyloarthritis 146
Collagen Specific T-Cell Repertoire and HLA-DR Alleles: Biomarkers of Active Refractory Rheumatoid Arthritis 146
COVID-19 atypical Parsonage-Turner syndrome: a case report 145
Has shoulder ultrasonography got a predictive value in Polymialgia Rheumatica. In: EULAR. 143
Malnutrition in COVID-19 survivors: prevalence and risk factors 140
Malnutrition in COVID-19 survivors: prevalence and risk factors 140
Tapering and discontinuation of TNF-α blockers without disease relapse using ultrasonography as a tool to identify patients with rheumatoid arthritis in clinical and histological remission 139
Synovial features of patients with rheumatoid arthritis and psoriatic arthritis in clinical and ultrasound remission differ under anti-TNF therapy: A clue to interpret different chances of relapse after clinical remission? 139
Residual respiratory impairment after COVID-19 pneumonia 139
Synovial tissue derived characteristics are included in a nomogram for the prediction of treatment response in naïve Rheumatoid Arthritis 138
Sarilumab use in severe SARS-CoV-2 pneumonia 136
Quantitative and semi-quantitative computed tomography analysis of interstitial lung disease associated with systemic sclerosis: A longitudinal evaluation of pulmonary parenchyma and vessels 132
Systemic Bone Density at Disease Onset Is Associated With Joint Erosion Progression in Early Naive to Treatment Rheumatoid Arthritis: A Prospective 12-Month Follow-Up Open-Label Study 132
Recommendations for the use of biologic therapy in rheumatoid arthritis: update from the Italian Society for Rheumatology I. Efficacy 131
Psychological Distress After Covid-19 Recovery: Reciprocal Effects With Temperament and Emotional Dysregulation. An Exploratory Study of Patients Over 60 Years of Age Assessed in a Post-acute Care Service 129
PTPN22 1858C>T polymorphism distribution in Europe and association with rheumatoid arthritis: case-control study and meta-analysis 128
Clinical and ultrasonographic remission determines different chances of relapse in early and long standing rheumatoid arthritis. 128
Effects of l-Arginine Plus Vitamin C Supplementation on Physical Performance, Endothelial Function, and Persistent Fatigue in Adults with Long COVID: A Single-Blind Randomized Controlled Trial 127
Collagen Specific T-Cell Repertoire and HLA-DR Alleles: Biomarkers of Active Refractory Rheumatoid Arthritis 125
Characterization of inflammatory cell infiltrate of scleroderma skin: B cells and skin score progression. 125
Baseline shoulder ultrasonography is not a predictive marker of response to glucocorticoids in patients with polymyalgia rheumatica: A 12-month followup study 124
Selective Inhibitors of T Cell Receptor Recognition of Antigen–MHC Complexes for Rheumatoid Arthritis 124
Obesity as a risk and severity factor in rheumatic diseases (autoimmune chronic inflammatory diseases) 122
Durable renal response and safety with add-on belimumab in patients with lupus nephritis in real-life setting (BeRLiSS-LN). Results from a large, nationwide, multicentric cohort 120
No higher risk of respiratory symptoms in Italian rheumatological patients under IL-6R-inhibitor therapy in SARS-CoV-2 pandemic 117
Biomolecular features of inflammation in obese rheumatoid arthritis patients: management considerations 116
Early vedolizumab trough levels predict treatment persistence over the first year in inflammatory bowel disease 115
Effects of l-Arginine Plus Vitamin C Supplementation on l-Arginine Metabolism in Adults with Long COVID: Secondary Analysis of a Randomized Clinical Trial 114
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 114
Body weight, gender and response to TNF-α blockers in axial spondyloarthritis 114
Biomarkers of Good EULAR Response to the B Cell Depletion Therapy in All Seropositive Rheumatoid Arthritis Patients: Clues for the Pathogenesis 111
IL COINVOLGIMENTO ARTICOLARE NEL LES: LA FORMA CLASSICA E LA VARIANTE “RHUPUS” 111
Is Citrullination Required for the Presence of Restricted Clonotypes Reacting With Type II Collagen? Comment on the Article by Chemin et al 111
Cardiac troponin T and NT-proBNP as diagnostic and prognostic biomarkers of primary cardiac involvement and disease severity in systemic sclerosis: A prospective study 111
Rituximab Followed by Belimumab Controls Severe Lupus Nephritis and Bullous Pemphigoid in Systemic Lupus Erythematosus Refractory to Several Combination Therapies 110
Checkpoint inhibitors (CPI) and autoimmune chronic inflammatory diseases (ACIDs): tolerance and loss of tolerance in the occurrence of immuno-rheumatologic manifestations 107
Immune-Guided Therapy of COVID-19 107
Comparative analysis of synovial inflammation after SARS-CoV-2 infection 106
Extension of Lung Damage at Chest Computed Tomography in Severely Ill COVID-19 Patients Treated with Interleukin-6 Receptor Blockers Correlates with Inflammatory Cytokines Production and Prognosis 105
Simultaneous onset of mycobacterium kansasii pulmonary infection and systemic lupus erythematosus: A case report 105
The metabolic syndrome: the crossroads between rheumatoid arthritis and cardiovascular risk 104
Intensive training programme for ultrasound-guided minimally invasive synovial tissue biopsy on knees and wrists in different phases of inflammation 103
Development and validation of a new algorithm for attribution of neuropsychiatric events in systemic lupus erythematosus 103
Five-year survival on infliximab in rheumatoid arthritis patients: analysis from an Italian registry (GISEA) by different calendar years 103
CTLA-4 Ig as an effective treatment in a patient with type I diabetes mellitus and seropositive rheumatoid arthritis 103
Paradoxical arthritis occurring during anti-TNF in patients with Inflammatory Bowel Disease: histological and immunological features of a complex synovitis. 103
Therapeutic drug monitoring is more cost-effective than a clinically-based approach in the management of loss of response to infliximab in inflammatory bowel disease: an observational multi-centre study. 103
Case report: Dupilumab treatment improved type 2 disorders in a patient with IPEX syndrome diagnosis 102
Long-term retention rate of anakinra in adult onset Still’s disease and predictive factors for treatment response. 102
Estimated 10-year cardiovascular risk in a large Italian cohort of rheumatoid arthritis patients: Data from the Cardiovascular Obesity and Rheumatic DISease (CORDIS) Study Group 102
Infectious agents breaking the immunological tolerance: The holy grail in rheumatoid arthritis reconsidered 102
Efficacy and safety of rituximab with and without methotrexate in the treatment of rheumatoid arthritis patients: results from the GISEA register 101
Immunosuppressive Therapy (Methotrexate or Cyclophosphamide) in Combination with Corticosteroids in the Treatment of Giant Cell Arteritis: Comparison with Corticosteroids Alone 101
Adult Onset Still's Disease and Radiotherapy treatment for breast cancer: Case report about management of this rare association and literature review 101
Gut microbiota analysis in systemic sclerosis according to disease characteristics and nutritional status 101
Rituximab Followed by Belimumab Controls Severe Lupus Nephritis and Bullous Pemphigoid in Systemic Lupus Erythematosus Refractory to Several Combination Therapies 101
Collagen Specific T-Cell Repertoire and HLA-DR Alleles: Biomarkers of Active Refractory Rheumatoid Arthritis 100
Microvascular heart involvement in systemic autoimmune diseases: The purinergic pathway and therapeutic insights from the biology of the diseases 99
Very early rheumatoid arthritis as a predictor of remission: a multicentre real life prospective study 98
Rheumatoid arthritis and Alzheimer's disease: genetic and epigenetic links in inflammatory regulation 98
Polymorphisms of the IgH enhancer HS1.2 and risk of systemic lupus erythematosus 98
Interleukin-6 and IgA-rheumatoid factor are crucial for baseline erosiveness, and anti-citrullinated peptide antibodies for radiographic progression in early rheumatoid arthritis treated according to a treat-to-target strategy 98
No higher risk of respiratory symptoms in Italian rheumatological patients under IL-6R-inhibitor therapy in SARS-CoV-2 pandemic 98
An unusual lung involvement in scleroderma: lipoid pneumonia 98
Switching from IFX originator to biosimilar CT-P13 does not impact effectiveness,safety and immunogenicity in a large cohort of IBD patients 98
Refractory adult-onset Still disease complicated by macrophage activation syndrome and acute myocarditis: A case report treated with high doses (8mg/kg/d) of anakinra. 96
Use of First-Line Oral Analgesics during and after COVID-19: Results from a Survey on a Sample of Italian 696 COVID-19 Survivors with Post-Acute Symptoms 95
Synovial predictors of differentiation to definite arthritis in patients with seronegative undifferentiated peripheral inflammatory arthritis: MicroRNA signature, histological, and ultrasound features 95
Totale 14.569
Categoria #
all - tutte 113.146
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 113.146


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021713 0 0 0 0 0 87 114 21 164 98 187 42
2021/20221.771 198 110 56 104 110 54 40 224 88 127 258 402
2022/20234.037 455 473 356 669 326 510 195 286 448 106 131 82
2023/20242.242 86 549 83 104 92 350 193 90 40 119 295 241
2024/20254.393 104 101 352 175 357 176 184 187 679 451 849 778
2025/20266.261 1.664 385 729 1.337 1.791 355 0 0 0 0 0 0
Totale 24.140